RECOMMANDATION DECEMBRE 2019

Adénocarcinome du Pancréas

L’ACHBT a dirigé l’élaboration des recommandations INCa (Institut National du Cancer) sur l’Adénocarcinome du Pancréas publiées fin 2019. Ce travail a été mené sous la direction d’Alain Sauvanet (Beaujon) en collaboration avec E. Buc (Clermont-Ferrand),  JR Delpero (Marseille), S. Truant (Lille) et L. Schwarz (Rouen).

​

Les 2 textes (Thésaurus et Synthèse) sont téléchargeables ci-après :

​

1. Thésaurus "CONDUITES À TENIR DEVANT DES PATIENTS ATTEINTS D’ADÉNOCARCINOME DU PANCRÉAS"

2. Synthèse "CONDUITES À TENIR DEVANT DES PATIENTS ATTEINTS D’ADÉNOCARCINOME DU PANCRÉAS"

 

Cancérologie générale

Cancérologie digestive : pratiques chirurgicales.

Slim K et al. Recommandations de la societe francaise de chirurgie digestive (SFCD) et de l’association de chirurgie hepatobiliaire et de transplantation hepatique (ACHBT)

 
Métastases hépatiques de cancer colo-rectal

Cancer colorectal métastatique

Phelip JM et al. Thésaurus National de Cancérologie Digestive, février 2014, [http://www.snfge.org/tncd] (link is external)

 

Prise en Charge des patients atteints de métastases hépatiques synchrones du cancer colorectal.

Mariette et al. Recommandations pour la Pratique Clinique 2011

 

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

Nordlinger B et al. Lancet 2008 ; 22;371:1007-16

 

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Nordlinger B et al. Lancet Oncol. 2013;14:1208-15

 

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Adam R et al. Ann Surg. 2004;240:1052-61

 

Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Adam R et al. Ann Surg. 2000;232:777-85.

 

Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.

Azoulay D et al. Ann Surg. 2000;231:480-6.

 

Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases.

Wicherts DA et al. Ann Surg. 200;248:994-1005

 

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.

Brouquet A et al. J Clin Oncol. 2011;29:1083-90

 

R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

de Haas RJ et al Ann Surg. 2008;248:626-37

 

Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

Andreou A et al Ann Surg. 2013;257:1079-88

 

Repeat hepatectomy for recurrent colorectal metastases.

Wicherts DA et al. Br J Surg. 2013;100:808-18

 

Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.

Mentha G et al. Br J Surg. 2006;93:872-8.

 

Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?

Brouquet A et al .J Am Coll Surg. 2010;210:934-41.

 

A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study.

Andres A et al Ann Surg. 2012;256:772-8.

 

Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Schnitzbauer AA et al., Ann Surg. 2012;255:405-14.

 

Early survival and safety of ALPPS: first report of the International ALPPS Registry.

Schadde E et al. Ann Surg. 2014;260:829-36

 

The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.

Adam R et al. Oncologist. 2012;17:1225-39

 

Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

Adam R. et al Cancer Treat Rev. 2015;41:729-41

 
Métastases hépatiques de tumeurs endocrines

 

Recommendations for management of patients with neuroendocrine liver metastases

Frilling A et al. Lancet Oncol. 2014;15

 
Carcinome hépato-cellulaire

 

«Carcinome hépatocellulaire».

Blanc JF et al. Thésaurus National de Cancérologie Digestive , mars 2014, [http://www.tncd.org (link is external) ]

 

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

European Association For The Study Of The Live (link is external)r. J Hepatol. 2012;56:908-43.

 

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Omata M et al. Hepatol Int. 2010;4:439-74

 

Surgical treatment of hepatocellular carcinoma: expert consensus statement.

Jarnagin W et al. HPB (Oxford). 2010;12:302-10

 

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.

Cherqui D et al.  Ann Surg. 2009;250:738-46

 

Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.

Sapisochin G et al. Ann Surg Oncol. 2013;20:1194-202

 

Hepatocellular carcinoma--resection or transplant?

Fan ST. Nat Rev Gastroenterol Hepatol. 2012

 

Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.

Fuks D et al. Hepatology. 2012;55:132-40.

 

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study

Vitale A et al. J Hepatol. 2015;62:617-24

 

Anatomical versus non-anatomical resection for hepatocellular carcinoma.

Marubashi S et al. Br J Surg. 2015;102:776-84.

 
Cholangiocarcinome

 

«Cancer des voies biliaires»

Malka et al. Thésaurus National de Cancérologie Digestive, janvier 2014, [http://www.snfge.org/tncd] 

 

Hilar cholangiocarcinoma: expert consensus statement.

Mansour JC et al, HPB (Oxford). 2015;17:691-9

 

Intrahepatic cholangiocarcinoma: expert consensus statement.

Weber SM et al. HPB (Oxford). 2015;17:669-80

 

 

Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis

Mavros MN  et al. JAMA Surg. 2014.

 

Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma

Neuhaus P et al, Ann Surg Oncol. 2012;19:1602-8.

 

Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma.

Farges O et al.  Br J Surg. 2013;100:274-83

 

Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group.

Regimbeau JM et al, HPB (Oxford). 2015 ;17:79-86

 

A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.

Hyder O et al, JAMA Surg. 2014;149:432-8

 
Adenome

 

Hepato-cellular adenoma subtype classification using molecular markers and immunohistochemistry.

Bioulac-Sage P et al. Hepatology 2007; 46: 740–8.

 

Resection, transplantation and local regional therapies for liver adenomas.

Dokmak S et al. J. Expert Rev Gastroenterol Hepatol. 2014;8:803-10.

 

 

A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.

Dokmak S et al. Gastroenterology. 2009;137:1698-705

 

 
Transplantation hépatique

 

Indications de la transplantation hépatique.

Boudjema et al. Conférence de consensus 2005.

 

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. (link is external)

Clavien PA, Lancet Oncol. 2012;13(1):e11-22

 

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Mazzaferro V et al. N Engl J Med. 1996 14;334:693-9.

 

Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. 

Duvoux C et al. Gastroenterology. 2012;143:986-94

 

Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.

De Vreede I et al, Liver Transpl. 2000;6:309-16.

 

Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers 

Darwish Murad S et al. Gastroenterology. 2012;143:88-98.

 

Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.

Le Treut YP et al. Ann Surg. 2013;257:807-15

 

Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?

Dueland S et al. Ann Surg. 2015;261:956-60.

 

Orthotopic liver transplantation with preservation of the inferior vena cava.

Tzakis AG et al. Ann Surg. 1989;210:649-52.

 

A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion.

Belghiti J et al. Surg Gynecol Obstet. 1992 Sep;175(3):270-2.

 

Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans.

Tzakis AG et al. Surg Gynecol Obstet. 1993;176(2):180-2

 

Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study.

Figueras J et al. , Liver Transpl. 2001;7:904-11

 

Randomized trial of choledochocholedochostomy with or without a T tube in orthotopic liver transplantation.

Scatton O et al. Ann Surg. 2001;233:432-7